trauma wound News
-
Reprise Biomedical Completes Spin-off from Miromatrix Medical
Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology, has successfully completed a $12.5 million private placement and commenced operations as a spin-off from Miromatrix Medical Inc. Through the spin-off, Miromatrix transferred to Reprise two existing FDA 510(k) cleared, ...
-
A new member joins our Medical Advisory Board
We would like to announce that Dr. Maria Mani is our newest member of our Medical Advisory Board. Maria is an associate professor, senior lecturer and director of the plastic and reconstructive microsurgery department at the Uppsala University Hospital. ...
-
Creative Proteomics Cytokine Launches High-Sensitivity Inflammation Cytokines Assay to Support Your Research
Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics is proud to announce the launch of the high-sensitivity inflammatory cytokine assays. These assays offer ultra-sensitivity, excellent ...
-
TissueTech Announces Rebranding, Adopts BioTissue Name Across Entire Business
TissueTech, Inc.—a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions—has unveiled a corporate rebranding, including a name change and a new logo. BioTissue, Inc. and Amniox Medical, Inc. will now both be known under a single commercial, customer facing entity, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you